BiotechTube
Home/Tridek-One/Laurence de Schoulepnikoff
LD

Laurence de Schoulepnikoff

CEO

Tridek-One

Therapeutic Areas

Autoimmune DiseasesInflammatory Diseases

Tridek-One Pipeline

DrugIndicationPhase
CD31-ITAM Bispecific PlatformAutoimmune and Inflammatory DiseasesPre-clinical

Leadership Team at Tridek-One

JA
Jean-François Arrighi, PhD
CSO
OL
Olivier Léger, PhD
SVP Biologics Engineering
RO
Régis Olivier
CFO
GC
Giuseppina Caligiuri, MD, PhD
Scientific Founder
PA
Prof. Antonino Nicoletti, PhD
Scientific Founder
View full Tridek-One profile